Cancer type

• Policy & Insight

MPs vote in favour of the Tobacco and Vapes Bill at its Second Reading

Today marked the second reading of the Tobacco and Vapes Bill in Parliament, where MPs were able to vote on the Bill for the first time. So what's next? Today marked the second reading of the Tobacco and Vapes Bill in Parliament, where MPs were able to vote on the Bill for the first time. So what's next?

26 November 2024

• Charity News

£4m funding renewal for lung cancer research in Manchester and London

The Lung Cancer Centre of Excellence (LCCE) in Manchester and London will continue their groundbreaking research with up to £4m of funding support from ScottishPower.  The Lung Cancer Centre of Excellence (LCCE) in Manchester and London will continue their groundbreaking research with up to £4m of funding support from ScottishPower. 

20 November 2024

• Health & Medicine

100 lives saved from lung cancer every day

Almost 668,000 lives have been saved from lung cancer in the UK since the 1970s, according to our latest analysis. We're working to save more. Almost 668,000 lives have been saved from lung cancer in the UK since the 1970s, according to our latest analysis. We're working to save more.

14 November 2024

• Science & Technology

Could a chemical found in red grapes prevent bowel cancer?

Scientists, funded by Cancer Research UK, are finding out if an ingredient commonly found in red grapes could hold the answer to help prevent bowel cancer. Scientists, funded by Cancer Research UK, are finding out if an ingredient commonly found in red grapes could hold the answer to help prevent bowel cancer.

11 November 2024

• Science & Technology
• Health & Medicine

NICE recommends elranatamab for adults with a rare form of blood cancer

The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell. The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell.

1 November 2024

• For Researchers

The road to curing the incurable

Dr Lucy Brooks talks glioblastoma microenvironments and her excitement around potential new treatments Dr Lucy Brooks talks glioblastoma microenvironments and her excitement around potential new treatments

30 October 2024

• Personal Stories

“Do whatever you can, I need to live - I have my little girl”: Lina's story

Lina tells the story of how a newly available targeted drug helped slow down the growth of faulty BRCA-driven cancer in her body, giving her more time to spend with her loved ones. Lina tells the story of how a newly available targeted drug helped slow down the growth of faulty BRCA-driven cancer in her body, giving her more time to spend with her loved ones.

28 October 2024

• Charity News
• Science & Technology

£3m for world-first trial to revolutionise brain cancer treatment

A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.   A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.  

23 October 2024